Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Total revenue	$ 168,149	$ 913,444
Operating expenses
Cost of products sold	73,236	592,378
Cost of services	1,575	128,306
Research and development, net	25,856	1,812,831
General and administrative	1,684,151	2,423,953
Sales and marketing	128,646	1,026,087
Total operating expenses	1,913,464	5,983,555
Operating loss	(1,745,315)	(5,070,111)
Other income (expense)
Interest and other income	10	30,106
Gain on impairment adjustment	2,079,575
Interest expense		(617,298)
Foreign currency transaction gains (losses)	281	(91,994)
Change in fair value of derivative financial instruments		12,694
Change in fair value of EIB loan guaranty	(46,584)
Total other income (expense)	2,033,282	(666,492)
Income (loss) before income taxes	287,967	(5,736,603)
Provision for income taxes
Net income (loss)	287,967	(5,736,603)
Net income (loss) allocated to preferred stockholders	(84,462)
Net income (loss) available to common stockholders	$ 203,505	$ (5,736,603)
Earnings (loss) per share attributable to common stockholders
Basic	$ 0.158	$ (12.53)
Diluted	$ 0.154	$ (12.53)
Weighted average shares outstanding
Basic	1,284,305	457,727
Diluted	1,331,578	457,727
Net income (loss)	$ 287,967	$ (5,736,603)
Other comprehensive income - foreign currency translation		153,067
Comprehensive income (loss)	287,967	(5,583,536)
Product [Member]
Revenue
Total revenue	141,373	410,897
Service [Member]
Revenue
Total revenue	26,776	21,673
Collaborations Revenue [Member]
Revenue
Total revenue		$ 480,874